Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

278
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
278
Correlations02:20

Correlations

36.1K
Correlation means that there is a relationship between two or more variables (such as ice cream consumption and crime), but this relationship does not necessarily imply cause and effect. When two variables are correlated, it simply means that as one variable changes, so does the other. We can measure correlation by calculating a statistic known as a correlation coefficient. A correlation coefficient is a number from -1 to +1 that indicates the strength and direction of the relationship between...
36.1K
Correlation and Causation01:27

Correlation and Causation

42.8K
Statistical tests can calculate whether there is a relationship, or correlation, between independent and dependent variables. An indirect relationship of the variables signifies a correlation, while a direct relationship shows causation. If it is determined that no connection exists between the variables, then the correlation is a coincidence.
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...
42.8K
Correlation01:09

Correlation

15.2K
In statistics, two variables are said to be correlated if the values of one variable are associated with the other variable. Depending on the relationship between two variables, correlation can be of three types– positive correlation, negative correlation, and zero correlation.
Two variables, for example, a and b, are said to be positively correlated if both variables move in the same direction. In other words, a positive correlation exists between two variables, a and b, if:
15.2K
Growth Models with Integration: Problem Solving01:27

Growth Models with Integration: Problem Solving

57
In population modeling, integration provides a systematic way to determine accumulated quantities from known rates of change. One such application arises in ecology, where the total weight of a fish population in a body of water is referred to as its biomass. When the rate of growth of this biomass is known as a function of time, calculus can be used to determine the total biomass at a future date.Growth Rate and Biomass FunctionLet the growth rate of the fish population be represented by a...
57
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

234
Body:Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts.
234

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the Interplay Between Prior Weight and Variance of the Robustification Component in Robust Mixture Prior Bayesian Dynamic Borrowing Approach.

Statistics in medicine·2026
Same author

Innovative Clinical Trial Approach for Evaluating Digital Medical Devices Under European Fast-Track Regulatory Frameworks.

Statistics in medicine·2026
Same author

New, Shorter Small-Sample Intervals for Vaccine Efficacy.

Pharmaceutical statistics·2026
Same author

Optimal preclinical models for human dose projection of SARS-CoV-2 small molecule direct-acting antivirals.

Antiviral research·2026
Same author

Dual-Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time-to-Event Group Sequential Trials.

Statistics in medicine·2026
Same author

Estimating the Optimal Time to Perform a Positron Emission Tomography With Prostate-Specific Membrane Antigen in Prostatectomized Patients, Based on Data From Clinical Practice.

Biometrical journal. Biometrische Zeitschrift·2025

Related Experiment Video

Updated: Feb 4, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

7.3K

Bayesian knowledge integration for an in vitro-in vivo correlation model.

Elvira M Erhardt1, Moreno Ursino2, Jeike Biewenga3

  • 1Department of Mathematical Sciences, Politecnico di Torino, 10129, Torino, Italy.

Biometrical Journal. Biometrische Zeitschrift
|September 28, 2018
PubMed
Summary
This summary is machine-generated.

This study introduces a novel Bayesian framework for in vitro-in vivo correlation (IVIVC) to reliably predict drug concentration over time. This advanced IVIVC approach enhances formulation development by integrating diverse data, reducing the need for human bioequivalence trials.

Keywords:
Bayesianin vitro-in vivo correlation (IVIVC)ordinary differential equation (ODE)pharmacokineticstransdermal patch

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.6K
In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition
09:05

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition

Published on: August 20, 2016

8.4K

Related Experiment Videos

Last Updated: Feb 4, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

7.3K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.6K
In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition
09:05

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition

Published on: August 20, 2016

8.4K

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Computational Biology
  • Drug Delivery Systems

Background:

  • Traditional in vitro-in vivo correlation (IVIVC) models often use frequentist methods, leading to complex deconvolution and potential instability.
  • Current IVIVC approaches may struggle with formulations exhibiting extended release or absorption lag times.
  • There is a need for more robust and flexible IVIVC methods to support formulation changes without extensive bioequivalence testing.

Purpose of the Study:

  • To develop and validate a novel Bayesian framework for in vitro-in vivo correlation (IVIVC).
  • To enable reliable prediction of in vivo serum concentration-time profiles from in vitro drug release data.
  • To support formulation development and reduce the need for additional bioequivalence trials.

Main Methods:

  • A nonlinear-mixed effects model for in vitro release data.
  • A population pharmacokinetic (PK) compartment model for in vivo immediate release (IR) data.
  • A Bayesian hierarchical model integrating submodels (a) and (b) using ordinary differential equations (ODEs) for controlled release (CR) prediction.

Main Results:

  • The proposed Bayesian approach effectively integrates in vitro and in vivo data, accounting for parameter uncertainty.
  • Splitting the parameter space and using estimates as priors in a hierarchical model enhances flexibility.
  • The method demonstrated successful application in predicting the performance of a transdermal patch (TD).

Conclusions:

  • The developed Bayesian IVIVC framework offers a flexible and robust alternative to traditional frequentist methods.
  • This approach facilitates knowledge transfer between in vitro and in vivo studies, accommodating varying data complexities.
  • The method has the potential to streamline drug formulation development and regulatory processes.